IUBio Biosequences .. Software .. Molbio soft .. Network News .. FTP

Taq patent

Louis Hom lhom at OCF.Berkeley.EDU
Mon Jan 31 18:50:42 EST 2000


If I recall correctly, the fraudulent part of the patent application had
to do with the description of the prior art (they failed to disclose
that relevant work had been done previously in a Russian lab(?) that they
knew about), thus affecting what was "novel" about the work described in
the patent.  It sounds like a problem that occurred in the technology
office AFTER the bench work was done and the notebooks were turned
in.  (Am I implying that scientists are more scrupulous than lawyers?  not
intentionally.)

As for patents and progress, remember that the process for making MAbs
didn't get patented.  Maybe monoclonals didn't revolutionize molecular
biology the same way that PCR did, but I think they did lead to some great
discoveries and some interesting derivative technologies.
-- 
______________________________________________________________________________
Lou Hom >K'93			     
lhom at ocf.berkeley.edu		
http://www.ocf.berkeley.edu/~lhom/ 	    




More information about the Methods mailing list

Send comments to us at biosci-help [At] net.bio.net